Week of April 18, 2022 | Vol. 11, Issue 16
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory
Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
May 17-19, 2022 - Philadelphia, PA
May 24-26, 2022 - New York City, NY
April 23-26, 2022 - Palm Beach, FL
June 13-16, 2022 - San Diego, CA
August 27-29, 2022 - Boston, MA
October 2022 - Charlotte, NC
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS
Pharma & Biotech
6 transactions totaling $2,540 million

Supplies, Equipment & Services
14 transactions totaling $391 million

Healthcare IT & Managed Care
5 transactions totaling $120 million

Healthcare Facilities & Distributors
4 transactions totaling $63 million
PRIVATE PLACEMENTS
Pharma & Biotech
40 transactions totaling $720 million

Supplies, Equipment & Services
29 transactions totaling $434 million

Healthcare IT & Managed Care
14 transactions totaling $89 million

Healthcare Facilities & Distributors
5 transactions totaling $61 million
PUBLIC OFFERINGS
Pharma & Biotech
24 transactions totaling $1,359 million

Supplies, Equipment & Services
5 transactions totaling $60 million

Healthcare IT & Managed Care
1 transaction totaling $4 million

Healthcare Facilities & Distributors
0 transactions
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Gateway
Sell-side | Pharma | Generic pharmaceuticals

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
Tanner Pharma announced today its expansion to Ireland with the opening of a new office space in Cork, the country’s third largest city. The new location was selected after many months of travel and research by Tanner’s executive team.

With the withdrawal of the United Kingdom from the European Union, it was essential for Tanner to maintain a presence in the EU—and Ireland was a natural fit. This location will allow ease of distribution to EU countries, enabling the company to further enhance accessibility to life-improving medicines and better serve patients.

Fred Baldwin will serve as Director of the new Irish segment, helping to support financial and strategic operations. Michelle Cahill will fulfill the role of Responsible Person to ensure Good Distribution Practices (GDP) are met, and Vinu Chandy will serve as Order Management Executive to support business actions. The company has acquired a Wholesale Distribution Authorisation for this region through the Health Products Regulatory Authority (HPRA).
As Pfizer plans to lean in on producing its COVID-19 antiviral this year the drugmaker is looking to pick up the developer of a diagnostic smartphone app, which could help get tablets into patients’ hands faster.
Small but mighty transatlantic investment firm Abingworth has caught the attention—and appetite—of the Carlyle Group, who took the opportunity to gain a stronger foothold in life sciences.
Northwell Health and startup studio Aegis Ventures formed a new joint venture last fall that aims to create novel artificial intelligence tools for patient care.
Move over, A: B is taking the lead now, with Be Biopharma closing out a $130 million financing round backed by several industry leaders that will fuel its engineered B cells platform.

TannerMAP works across the broad spectrum of pharma services, creating opportunities that benefit manufacturers and patients alike. Learn more about the division from industry veterans and Tanner EVPs, Rob Keel and John Lagus.

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.